Back

Anemia and outcome in cardiac amyloidosis

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (1) - Cardiac amyloidosis (1) Infiltrative Myocardial Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Giuseppe Imperatore

Pisa (Italy)

9 More presentations in this session

Presentation thumbnail
Discussant - Cardiac amyloidosis (1)
Presentation thumbnail
The role of nutritional status, measured by serum albumin, as a prognostic factor in wild-type transthyretin amyloidosis
Mr S. Decotto (Buenos Aires, AR)
Abstract Slides Video
Presentation thumbnail
Clinical characteristics and follow-up outcomes of patients with wild-type transthyretin amyloidosis: comparison of the pre- and post-bone scintigraphy eras in a Latin American center.
Miss P. Domenech (Buenos Aires, AR)
Abstract Slides Video
Presentation thumbnail
Wild-type transthyretin cardiac amyloidosis: sex differences in prevalence, phenotype, and prognosis
Assistant Professor A. Zaroui (Creteil, FR)
Abstract Slides Video
Presentation thumbnail
Predictors of major adverse cardiovascular events in patients with wild-type transthyretin amyloid cardiomyopathy: insights from a regional hospital experience
Doctor A. Martins (Leiria, PT)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (1) - Cardiac amyloidosis (1)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
Transthyretin cardiac amyloidosis
thumbnail
Congress Session
Cardiac amyloidosis from epidemiology to treatment
thumbnail
Congress Session
Amyloid cardiomyopathy: epidemiology, diagnosis, prognostic and treatment

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources